Subject Numbers Regarding Health Provider Authorizations
Authorization No. 163608-3W
October 10, 2023
Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Robert Lippe's authorization to treat injured workers within the New York State workers' compensation system effective October 5, 2023. Dr. Lippe's last known business addresses are:
660 Broadway
Massapequa, New York 11758
Orlin and Cohen Orthopedics Associates
444 Merrick Road
Lynbrook, New York 11563
Orlin and Cohen Orthopedics Associates
1728 Sunrise Highway
Merrick, New York 11566
Orlin and Cohen Orthopedics Associates
36 Lincoln Avenue
Rockville Centre, New York 11570
Orlin and Cohen Orthopedics Associates
3480 Veterans Memorial Highway
Bohemia, New York 11716
and
Orlin and Cohen Orthopedics Associates
1101 Stewart Avenue
Garden City, New York 11530
The Chair's designee's investigation has revealed that, despite multiple written requests, Dr. Lippe has failed and refused to provide the Board with proof of reimbursement of the sum of $647.03 to an injured worker's private health insurer, which sum having also been paid to Dr. Lippe by the workers' compensation insurer for the same treatment.
As a result of the foregoing, the Chair believes that Dr. Lippe may be guilty of misconduct under WCL §13-d(2)(f) for the refusal to produce "any relevant book or paper concerning his or her conduct under any authorization granted to him or her under this chapter."
Dr. Lippe is prohibited from rendering treatment and care to injured workers, and from conducting reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a), while his authorization is temporarily suspended. Reports submitted by Dr. Lippe for services rendered prior to October 5, 2023, are valid but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Lippe for services rendered prior to October 5, 2023, should not be denied due to the suspension of his authorization.
This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director's Office at 1 (800) 781-2362.
Clarissa M. Rodriguez
Chair